Efficacy and safety of cardiac myosin inhibitors in obstructive hypertrophic cardiomyopathy: Systematic review and comprehensive frequentist and Bayesian meta-analyses of Phase 3 randomized controlled trials

Authors

Iacopo Olivotto (ORCID: https://orcid.org/0000-0003-1751-9266)
Alasdair Henderson (ORCID: https://orcid.org/0000-0002-8903-4906)
Caroline Coats (ORCID: https://orcid.org/0000-0002-3208-470X)
Matthew M.Y. Lee (ORCID: https://orcid.org/0000-0001-9213-2067)
Ahmad Masri (ORCID: https://orcid.org/0000-0002-6390-6526)
Fraser C. Goldie

Institutions

Oregon Health & Science University (US)
Meyer Children's Hospital (IT)
Istituti di Ricovero e Cura a Carattere Scientifico (IT)
University of Glasgow (GB)

Publication Details

Journal: Progress in Cardiovascular Diseases
Published: 2025-10-13
DOI: https://doi.org/10.1016/j.pcad.2025.10.002
Citations: 4
Primary Topic: Cardiomyopathy and Myosin Studies
Type: article
Field-Weighted Citation Impact: 5.55

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and safety of cardiac myosin inhibitors in obstructive hypertrophic cardiomyopathy: Systematic review and comprehensive frequentist and Bayesian meta-analyses of Phase 3 randomized controlled trials

Iacopo Olivotto, Alasdair Henderson, Caroline Coats, Matthew M.Y. Lee et al.

Oct 13, 2025

4 citations

Progress in Cardiovascular Diseases

Cardiomyopathy and Myosin Studies

5.55

article

Efficacy and safety of cardiac myosin inhibitors in obstructive hypertrophic cardiomyopathy: Systematic review and comprehensive frequentist and Bayesian meta-analyses of Phase 3 randomized controlled trials

Iacopo Olivotto, Alasdair Henderson, Caroline Coats, Matthew M.Y. Lee, Ahmad Masri, Fraser C. Goldie

October 13, 2025article en

4 citations

Abstract

No abstract available for this paper.

Progress in Cardiovascular DiseasesVol. 94

Oregon Health & Science University (US), Meyer Children's Hospital (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Glasgow (GB)

Openalex Percentile: Top 3%

Cardiomyopathy and Myosin Studies

5.55

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of cardiac myosin inhibitors in obstructive hypertrophic cardiomyopathy: Systematic review and comprehensive frequentist and Bayesian meta-analyses of Phase 3 randomized controlled trials — Iacopo Olivotto, Alasdair Henderson, et al. · Progress in Cardiovascular Diseases (2025) | TGRS Research Map | TGRS